Airlock India Launches Healthy Cooking Cookware Trivedh™ in 15+ Cities
What makes the Trivedh™ Standalone in the Industry?
Unlike traditional cookware, Trivedh™ is crafted with a superior three-layered construction featuring stainless steel interiors, an aluminium core, and stainless-steel exteriors. The design makes sure that the heat is spread evenly, the food cooks faster, and consume up to 30% less gas, so that your every meal is a cost-effective treat.
With Trivedh™'s even heat distribution, users can reduce cooking times and save on energy bills. According to in-house estimates, switching to Trivedh™ can save up to ₹3,000 annually in fuel costs for an average Indian household—a clear win in today's inflationary times.
Below are the benefits you will be getting once you include Trivedh Tri-Ply in your household:
Healthier by Design
In an era where families are prioritizing wellness, Trivedh™ stands out by offers minimal oil usage, supporting weight management and heart health with certified food-grade materials, free from harmful chemicals or coatings. No PFOA, PTFE, or toxins, unlike traditional non-stick cookware
The honeycomb base further reduces sticking without relying on synthetic coatings, making it a safer choice for health-conscious homes.
From Kitchens to Communities
Airlock's success story goes far beyond product innovation. The brand has empowered a network of over 2,500 women entrepreneurs across India, who have been instrumental in driving awareness and adoption of its viral products through direct selling.
What started as a small idea has now become a rapidly growing brand expanding into over 15 Indian cities, with plans to enter more metros and Tier-2 markets by 2026.
Built for a Healthier India
As the market shifts towards sustainable, health-forward living, Airlock India is positioning itself not just as a cookware brand, but a lifestyle movement.
The range is available in multiple formats:
1. Tri-Ply Fry pans
2. Tri-Ply Sauce pans
3. Tri-Ply Dosa pans
Additionally, it comes with two powerful variants:
1. Trivedh™ Tri Ply Steel – Ideal for everyday cooking, without any coating
2. Trivedh™ Tri Ply with Honeycomb Base – Featuring Hexa-Tech for improved non-stick performance and durability
Each product is backed by a 7-year warranty, ensuring long-term savings and confidence for consumers.
This launch is another milestone in the company's meteoric rise, which is all about healthy living and cost-effective innovation. With a sharp eye on innovation and a heart set on impact, Airlock India's Trivedh™ range is poised to become a kitchen essential in every Indian household.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
3 hours ago
- Time of India
Superbugs threaten hospitals as antibiotic resistance rises: PGI study
1 2 Chandigarh: What if a simple cut or common infection turns deadly because our usual medicines no longer work? That's the scary reality of "superbugs" —bacteria that have become resistant to antibiotics due to overuse. A study led by doctors at PGIMER, Chandigarh, shows this problem is widespread in Indian hospitals, calling for urgent changes to how we use these life-saving drugs. The research looked at eight major hospitals across India: All India Institute of Medical Sciences (AIIMS), Bhopal; All India Institute of Medical Sciences (AIIMS), Rishikesh; All India Institute of Medical Sciences (AIIMS), Bathinda; All India Institute of Medical Sciences (AIIMS), Jodhpur; All India Institute of Medical Sciences (AIIMS), Gorakhpur; All India Institute of Medical Sciences (AIIMS), Raebareli; and Government Medical College, Baroda, with the central coordinating site being PGIMER, Chandigarh. The study, 'Antimicrobial Prescription Patterns in Tertiary Care Centres in India: A Multicentric Point Prevalence Survey', was conducted under the Society of Antimicrobial Stewardship Practices in India (SASPI). Led by Dr Nusrat Shafiq from PGIMER's clinical pharmacology unit – the central coordinating site – the survey analysed data from 3,974 patients. PGI was the nodal centre led by Dr Shafiq, the lead researcher from PGIMER. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like 15 Most Beautiful Female Athletes in the World Click Here Undo About 60% hospital patients were taking antibiotics. That's six out of every 10 people in the wards getting these drugs, often in intensive care units, revealed the study. Common antibiotics included ceftriaxone and metronidazole. Over half were from the 'Watch' group – stronger drugs the World Health Organization (WHO) says should be used carefully because they can speed up resistance. A small but worrying 5% were 'Reserve' drugs, like last-resort options for superbugs. Almost half the prescriptions were 'empiric', meaning doctors started them without laboratory tests to confirm the infection type. This is common when quick action is needed, but it can lead to unnecessary use. Many were for everyday infections caught outside the hospital (31%) or to prevent issues during surgery (31%). Hospital-caught infections made up 13% for the total infections, which is better than past studies but still a big concern. In some cases, up to half of the prescriptions were "irrational" – like giving drugs for too long or in the wrong dose. There were also "redundant" combos, where patients got extra drugs that didn't add much benefit but raised resistance risks. Common culprits were bacteria like E. coli and Acinetobacter, often in patients with long hospital stays or medical devices. Older hospitals like PGIMER, which handle more serious cases from referrals, used stronger drugs more often. These places see patients with weakened immune systems, such as those with cancer or transplants, making superbugs a bigger threat. Stay updated with the latest local news from your city on Times of India (TOI). Check upcoming bank holidays , public holidays , and current gold rates and silver prices in your area.
NDTV
5 hours ago
- NDTV
Conch Shell Blowing Shows Promise In Treating Sleep Apnea
A new study suggests that blowing a conch shell daily may help improve sleep for those with obstructive sleep apnea (OSA). The research, published as a randomized controlled trial, explored how playing wind instruments can support better breathing during sleep. OSA is a common condition affecting nearly one billion adults worldwide, marked by repeated pauses in breathing while sleeping. In the study, 30 individuals with moderate OSA were divided into two groups. One group practiced a traditional Indian breathing exercise called shankh, which involves blowing into a conch shell like a trumpet. The other group performed deep, slow nasal breathing exercises. Researchers observed that participants in the conch-blowing group showed significant improvements in sleep quality and reported feeling more refreshed upon waking, compared to the deep breathing group. The study was led by Dr Krishna K Sharma from the Eternal Heart Care Centre and Research Institute in Jaipur, India. He said: "The standard treatment for OSA is a continuous positive airway pressure machine, or CPAP, which keeps the patient's airway open by blowing air through a facemask throughout the night. While effective, many patients find it uncomfortable and struggle to use it consistently. "In my clinical practice, several patients reported feeling more rested and experiencing fewer symptoms after regularly practising shankh blowing - a traditional yogic breathing exercise involving exhaling through a conch shell. These observations led us to design a scientific study to rigorously test whether this simple, ancient practice could serve as a meaningful therapy for people with OSA." The findings indicate that conch-blowing exercises may strengthen respiratory muscles and keep airways clearer during sleep, offering a non-invasive method to manage sleep apnea symptoms.
Time of India
5 hours ago
- Time of India
Hyderabad among top 7 life sciences clusters globally
Hyderabad: Telangana's thriving life sciences sector has propelled Hyderabad into one of the top seven life sciences clusters in the world and the only Indian city to achieve this distinction, IT & industries minister Duddilla Sridhar Babu said on Wednesday. Tired of too many ads? go ad free now He said the sector attracted investments worth Rs 54,000 crore since Dec 2023, resulting in the creation of 2 lakh new jobs in pharmaceutical manufacturing, medical technology, and vaccine production. Pointing out that global giants such as Eli Lilly, Amgen, MSD, Zoetis, Evernorth, and Olympus have already chosen Hyderabad as their preferred GCC hub, he said Telangana will soon unveil its next-gen life sciences policy, which will be a "cutting-edge policy framework designed to attract large-scale investments." Sridhar Babu also said the state set an ambitious target to scale up its life sciences economy to $250 billion by 2030, with an eye on making Telangana the life sciences capital of Asia. The minister, who chaired the 6th board meeting of the Telangana Life Sciences Foundation in the city during the day, also proposed the preparation of a feasibility report for establishing the Telangana School of Life Sciences. The foundation's board members include Dr Reddy's Laboratories Chairman Satish Reddy, Laurus Labs CEO Dr Satyanarayana Chava, special chief secretary Sanjay Kumar, and Telangana life sciences director Shakti Nagappan.
